Pontifax Late Stage Fund L.p. - Net Worth and Insider Trading
Pontifax Late Stage Fund L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pontifax Late Stage Fund L.p. owns 2 companies in total, including Keros Therapeutics Inc (KROS) , and 89bio Inc (ETNB) .
Click here to see the complete history of Pontifax Late Stage Fund L.p.’s form 4 insider trades.
Insider Ownership Summary of Pontifax Late Stage Fund L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2020-04-07 | 10 percent owner |
| ETNB | 89bio Inc | 2019-11-11 | 10 percent owner |
Pontifax Late Stage Fund L.p. Trading Performance
Pontifax Late Stage Fund L.p. Ownership Network
Ownership Network List of Pontifax Late Stage Fund L.p.
Ownership Network Relation of Pontifax Late Stage Fund L.p.
Pontifax Late Stage Fund L.p. Owned Company Details
What does Keros Therapeutics Inc do?
Who are the key executives at Keros Therapeutics Inc?
Pontifax Late Stage Fund L.p. is the 10 percent owner of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Scientific Officer Jennifer Lachey , and Chief Operating Officer Christopher Rovaldi .
Keros Therapeutics Inc (KROS) Insider Trades Summary
Over the past 18 months, Pontifax Late Stage Fund L.p. made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante , a net sale of 250,000 shares made by Orbimed Advisors Llc , and a net sale of 250,000 shares made by Carl L Gordon .
In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 580,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 580,000 shares.
Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keros Therapeutics Inc Insider Transactions
Pontifax Late Stage Fund L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Pontifax Late Stage Fund L.p.. You might contact Pontifax Late Stage Fund L.p. via mailing address: 14 Shenkar Street, Beit Ofek, Herzliya Pituach L3 L3 46140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
